EMERGENT BIOSOLUTIONS INC (EBS) Stock Balance Sheet
USA - NYSE:EBS - US29089Q1058 - Common Stock
10.11 USD
-0.21 (-2.03%)
10.1321 USD
+0.02 (+0.22%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 245.50M | 99.50M | 111.70M | 642.60M | 576.10M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 149.50M | 154.50M | 191.00M | 159.20M | 274.70M | |||
| Inventories | 356.30M | 311.70M | 328.90M | 350.70M | 350.80M | |||
| Other Current Assets | 35.60M | 33.00M | 47.90M | 57.90M | 70.50M | |||
| Total Current Assets | 786.90M | 598.70M | 679.50M | 1.21B | 1.27B | |||
| Non-Current Assets | ||||||||
| PPE Net | 217.00M | 282.30M | 399.00M | 837.00M | 828.40M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | 0 | 218.20M | 224.90M | |||
| Intangibles | 452.70M | 501.50M | 566.60M | 728.80M | 604.60M | |||
| Other Non-Current Assets | 4.40M | 7.20M | 178.10M | 171.90M | 29.00M | |||
| Total Non-Current Assets | 674.10M | 791.00M | 1.14B | 1.96B | 1.69B | |||
| TOTAL ASSETS | 1.46B | 1.39B | 1.82B | 3.17B | 2.96B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | 0 | 413.70M | 957.30M | 31.60M | |||
| Accrued Expenses | 52.30M | 76.50M | 96.20M | 128.00M | 146.20M | |||
| Accounts Payable | 57.40M | 60.90M | 112.20M | 103.50M | 128.90M | |||
| Other Current Liabilities | 26.80M | 25.00M | 29.20M | 40.10M | 67.10M | |||
| Total Current Liabilities | 136.50M | 162.40M | 651.30M | 1.23B | 373.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 663.10M | 663.70M | 446.50M | 448.50M | 809.40M | |||
| Deferred Taxes/Income | 36.30M | 41.70M | 47.20M | 59.70M | 94.90M | |||
| Other Non-Current Liabilities | 42.60M | 39.10M | 28.90M | 41.50M | 61.90M | |||
| Total Non-Current Liabilities | 742.00M | 744.50M | 522.60M | 549.70M | 966.20M | |||
| TOTAL LIABILITIES | 878.50M | 906.90M | 1.17B | 1.78B | 1.34B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -105.20M | -212.40M | -21.80M | 738.70M | 957.80M | |||
| Additional Paid In Capital | 938.60M | 928.00M | 904.40M | 873.50M | 829.40M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -243.50M | -227.70M | -227.70M | -227.70M | -152.20M | |||
| Other Shareholders' Equity | -7.50M | -5.20M | -5.70M | 3.10M | -16.10M | |||
| Shares Outstanding | 52.70M | 54.30M | 52.20M | 50.10M | 51.30M | |||
| Tangible Book Value per Share | 2.463 | -0.3444 | 1.5843 | 8.7964 | 15.3899 | |||
| Total Shareholders' Equity | 582.50M | 482.80M | 649.30M | 1.39B | 1.62B | |||
| TOTAL LIABILITIES AND EQUITY | 1.46B | 1.39B | 1.82B | 3.17B | 2.96B | |||
| Statistics | ||||||||
| Debt/Equity | 1.14 | 1.37 | 0.69 | 0.32 | 0.50 | |||
| Current Ratio | 5.76 | 3.69 | 1.04 | 0.98 | 3.40 | |||
| Return On Assets (ROA) | 5.20% | -13.72% | -41.71% | -6.68% | 7.42% | |||
| Return On Equity (ROE) | 13.03% | -39.48% | -117.13% | -15.25% | 13.56% | |||
| Return On Invested Capital (ROIC) | 6.57% | N/A | N/A | N/A | 11.71% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 8.06% | N/A | N/A | N/A | 15.06% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 13.89% | N/A | N/A | N/A | 25.66% | |||
All data in USD , ROIC based on taxRate of 0.21